ArticleClinical ophthalmology (Auckland, N.Z.)2026
Knowledge, Attitudes, and Practices Toward Drug-Induced Visual Impairment Due to Antitubercular Therapy Among Medical Officers of Primary Health Care Centers in Karnataka, South India.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Ethambutol, a key first-line drug used in fixed-dose combinations for tuberculosis (TB) treatment, is associated with a well-known adverse effect, optic neuropathy, that can result in irreversible vision loss. Despite this risk, in high-burden countries such as India, the primary emphasis remains on disease elimination, often leading healthcare professionals to overlook the potential for serious vision-related side effects of ethambutol. This study sought to evaluate the knowledge, attitudes, and practices (KAPs) of medical officers at primary health centers (PHCs) in Karnataka regarding visual impairment caused by antitubercular therapy (ATT). Methods: A questionnaire-based, prospective, observational, cross-sectional study was conducted. Participants were recruited via a convenience sampling approach from PHCs in Karnataka. The data were analysed via IBM SPSS version 27. Results: Seventy-three medical officers responded to the questionnaire within the set period. Of these, 34.2% (25) were specialists, whereas 65.8% (48) were general practitioners. A majority (91.8%; 67) of the medical officers were actively involved in the diagnosis and treatment of TB patients, and 72.6% (53) of the medical officers claimed to have undergone a sensitisation program. A total of 75.3% (55) of the participants were aware of the visual complications of ATT. However, 69.9% (51) had never referred a patient with drug-induced visual impairment. A majority (95.9%) of the participants thought that there was a need for better awareness campaigns, and 91.8% of them felt that regular ophthalmic evaluations should be mandatory for patients on ATT. The mean KAP scores of specialists were significantly greater than those of general practitioners (p=0.002 unpaired Conclusion: The medical officers of PHCs in Karnataka believe that grassroots-level training, increased awareness, mandatory visual screening of visual function by a physician or optometrist at every PHC, and prompt referrals to tertiary care centers can help address the challenges in identifying drug-induced visual impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.